Internet-based cognitive behavior therapy for alcohol use and mental illness

Co-occurence of Mental Illness and Problematic Alcohol Use: an Internet-based Cognitive Behavior Therapy Intervention

Not applicable Interventional Linkoeping University · NCT06789250

This study is testing if an online therapy program can help adults with both alcohol problems and mild to moderate mental health issues feel better and drink less.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment240 (estimated)
Ages18 Years and up
SexAll
SponsorLinkoeping University Government
Locations2 sites (Linköping and 1 other locations)
Trial IDNCT06789250 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to evaluate the effectiveness of an internet-based cognitive behavior therapy (ICBT) program in treating adults with co-occurring problematic alcohol use and mild to moderate symptoms of mental illness, such as depression and anxiety. Participants will engage in a 10-week ICBT program, supported by a trained therapist, while a control group will receive weekly attention without the ICBT intervention. The study will measure changes in self-reported mental health and alcohol consumption. All participants must have access to the internet and be able to communicate in Swedish.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 and older who experience problematic alcohol use and mild to moderate symptoms of depression or anxiety.

Not a fit: Patients with severe psychiatric disorders, ongoing psychological treatment, or severe alcohol addiction requiring specialized treatment may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could provide an accessible and effective treatment option for individuals struggling with both alcohol use and mental health issues.

How similar studies have performed: Previous studies have shown promise for internet-based cognitive behavioral therapies in treating various mental health conditions, suggesting potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* AUDIT ≥ 6 points for women and ≥ 8 points for men
* Symptoms of depression, anxiety disorder and/or stress-related illness
* Adequate ability to speak, read and write Swedish
* Having access to the internet and a smartphone, computer or other device.

Exclusion Criteria:

* Ongoing psychological treatment.
* Ongoing medication for AUD
* Recent changes (within the past three months) in psychiatric medication or planned changes during the treatment period. New medication prescribed during the study shall be reported but will not lead to exclusion
* Severe psychiatric disorders based on a Mini-International Neuropsychiatric Interview (MINI) interview and reported medical history
* Severe medical conditions that may impede participation in the study
* Severe cognitive impairment
* Current suicidality
* Severe alcohol addiction where specialized treatment is more appropriate
* Risk for severe alcohol withdrawal symptoms with a need for medical treatment. Participation is possible after completing alcohol withdrawal treatment within the ordinary health-care system, accessible to the Swedish population.
* Substance use disorder, other than alcohol or nicotine, within the past six months.

Where this trial is running

Linköping and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Alcohol Drinking Related ProblemsAlcohol Use DisordersDepressive DisordersMental IllnessMental StressMental and Behavioral DisordersSleep ProblemsStress Disorders
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.